Clinical Trial Update: Weight Loss Effect of Akkermansia Muciniphila in Obese Patients [NA]

View source ↗

Summary

A completed clinical trial evaluated the weight loss effect of the gut microbe Akkermansia muciniphila in obese adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Akkermansia muciniphila (Akkermansia muciniphila)

Snippet

Sponsor: Wecare Probiotics Co., Ltd. | Conditions: 28≤BMI≤35Kg/m2 | NA | Status: COMPLETED